NCT05761990 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Jung JW, Kim YK
Scapular Dyskinesis in Elite Boxers with Neck Disability and Shoulder Malfunction. Medicina (Kaunas). 2021 Dec 9;57(12):1347. doi: 10.3390/medicina57121347.
Lacheta L, Horan MP, Nolte PC, Goldenberg BT, Dekker TJ, Millett PJ
SLAP Repair Versus Subpectoral Biceps Tenodesis for Isolated SLAP Type 2 Lesions in Overhead Athletes Younger Than 35 Years: Comparison of Minimum 2-Year Outcomes. Orthop J Sports Med. 2022 Jun 21;10(6):23259671221105239. doi: 10.1177/23259671221105239. eCollection 2022 Jun.

Effects Of A Novel Stretching Versus Post Isometric Relaxation Techniques On Shoulder Pain, Range Of Motion And Disability In Overhead Athletes With Glenohumeral Internal Rotation Deficits

Details for clinical trial NCT05761990

Clinical trial NCT05761990 - References